Jatenergy’s Stock Soars On The Day Of 2018 Annual General Meeting

Business man hand drawing a graph

On the day of its Annual General Meeting, Jatenergy shares traded at a higher level as stock price surged 5.634% to last trade at $0.075 on 21 November 2018.

During 2018, Jatenergy Limited (ASX: JAT) focused on developing its in-house brands organically and through strategic acquisitions. Recently, JAT completed the purchase of controlling stake in private company Green Forest that brings over 200 Australian duty free stores, gift shops, and daigou warehouses and more than 50 shops and pharmacies in Hong Kong. The company has also purchased 51% holdings in Sunnya that has strengthen JAT’s in-house products portfolio.  [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

JAT distributes a wide range of products including Neurio milk powder on TMall Global through Woolworths TMall flagship store and other TMall shopfronts. During 2018, its recently acquired milk product brand Golden Koala has produced a full cream milk powder, rich in calcium, and  a new premium ‘O-P-O’ infant formula.

Company’s strategy has demonstrated a strong growth in September quarter results with consolidated revenue of $10.68 million and estimated FY19 revenue in the vicinity of $65+ million.

Jatenergy and China based Shanghai Dragon Corporation have agreed to develop a fast-moving consumer goods brand named Cobbitty Country. Under the terms of contract, FMCG products including milk products, biscuits and other foods and beverages, toothpaste, soap, and other high volume FMCGs will be manufactured in Australia and packaged under the Cobbitty Country brand.

State controlled Shanghai Dragon Corporation is further executing online to-offline shopping  across approximately 3,000 of its new ‘Modern Living’ stores. Under O2O model, local retail stores provide consumers with the opportunity to familiarize themselves with products which are not available domestically. They then scan the product’s QR code to make the purchase and order home delivery, paying via mobile gateway.

In September 2018, JAT’s 50% owned Green Forest entered into a distribution agreement with the world’s sixth largest pharmaceutical company, Sinopharm to supply their “new retail” (online-to-offline) store rollout. As per the company’s information, Sinopharm is rolling O2O out nationally to approximately 5,000 stores.

China’s annual 11th November retail event also produced strong results for JAT products generally, and particularly for Sunnya’s NEURIO Formulated Milk Powder with Lactoferrin

While unleashing the company’s new retail strategy, JAT informed that in collaboration with Chinese business partners, the company will open a cornerstone retail outlet, ‘JAT Maternal and Infant Boutique’ in the children themed shopping centre, Hui Yue Kid’s City.

Over the past one-year, Jatenergy Limited’s stock has witnessed more than 2-fold increase in its daily price change. This translates a leap of 273.68% in JAT’s share price over the past 12-months as at 21 November 2018 with market capitalization of $49.71 million.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.



Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report